Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MARK2 Antikörper (AA 373-594) (HRP)

Dieses Anti-MARK2-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von MARK2 in ELISA. Geeignet für Human.
Produktnummer ABIN7169071

Kurzübersicht für MARK2 Antikörper (AA 373-594) (HRP) (ABIN7169071)

Target

Alle MARK2 Antikörper anzeigen
MARK2 (MAP/microtubule Affinity-Regulating Kinase 2 (MARK2))

Reaktivität

  • 77
  • 54
  • 45
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 73
  • 3
  • 1
Kaninchen

Klonalität

  • 65
  • 12
Polyklonal

Konjugat

  • 38
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser MARK2 Antikörper ist konjugiert mit HRP

Applikation

  • 47
  • 32
  • 17
  • 16
  • 11
  • 10
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
ELISA
  • Bindungsspezifität

    • 13
    • 8
    • 5
    • 5
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 373-594

    Kreuzreaktivität

    Human

    Aufreinigung

    >95%, Protein G purified

    Immunogen

    Recombinant Human Serine/threonine-protein kinase MARK2 protein (373-594AA)

    Isotyp

    IgG
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    MARK2 (MAP/microtubule Affinity-Regulating Kinase 2 (MARK2))

    Andere Bezeichnung

    MARK2

    Hintergrund

    Background: Serine/threonine-protein kinase involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4, MAPT/TAU, and RAB11FIP2. Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosphorylating RAB11FIP2. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Regulates axogenesis by phosphorylating KIF13B, promoting interaction between KIF13B and 14-3-3 and inhibiting microtubule-dependent accumulation of KIF13B. Also required for neurite outgrowth and establishment of neuronal polarity. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells.

    Aliases: ELKL motif kinase 1 antibody, ELKL motif kinase antibody, EMK-1 antibody, EMK1 antibody, MAP/microtubule affinity regulating kinase 2 antibody, MAP/microtubule affinity-regulating kinase 2 antibody, Mark2 antibody, MARK2_HUMAN antibody, MGC99619 antibody, PAR 1 antibody, Par 1b antibody, PAR1 homolog antibody, Par1b antibody, Ser/Thr protein kinase PAR 1B antibody, Serine/threonine protein kinase EMK antibody, Serine/threonine protein kinase MARK2 antibody, Serine/threonine-protein kinase MARK2 antibody

    UniProt

    Q7KZI7

    Pathways

    SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
Sie sind hier:
Chat with us!